Open AccessRifabutin‐based 10‐day and 14‐day triple therapy as a third‐line and fourth‐line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?
Author(s) -
Losurdo Giuseppe,
Ian Andrea,
Giorgio Floriana,
Principi Mariabeatrice,
Di Leo Alfredo,
Ierardi Enzo
Publication year - 2016
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640615623697
Subject(s) - rifabutin , medicine , regimen , helicobacter pylori , antibiotics , drug resistance , clarithromycin , intensive care medicine , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom